Atos and the Wellcome Genome Campus, in Cambridgeshire, UK, have announced a partnership to provide a global HPC, AI & Quantum Life Sciences Centre of Excellence to give researchers access to emerging HPC, AI & Quantum technologies
Christian Marcazzo, general manager at IDBS, highlights trends in life sciences research and development.
Christian Marcazzo, general manager at IDBS highlights trends in life sciences research and development
BC Platforms, a provider of genomic data management and analytics, has announces that Pfizer Finland will be using its technology solutions and research platform, including BCRQUEST.COM, to study data in cardiovascular diseases.
Some 44 per cent of life science professionals are using or experimenting with AI and deep learning, while 94 per cent expect an increase in use of machine learning within two years
Genomic sequencing may be about to get a lot faster with the application of optical co-processing technologies that are being deployed to accelerate sequence alignment – a technique that is necessary to establish functional, structural, or evolutionary relationships between the sequences
Geneformics, a provider of genomics IT infrastructures designed on advance the accessibility of transfer, storage and archiving of Next Generation Sequencing (NGS) data, has announced Geneformics D, a distributed cloud compression solution for genomics data.
Elsevier has announced that applications and nominations for The Hive, its innovation hub for biotech and pharmaceutical startups, are now open
The demand in Next Generation Sequencing (NGS) technology shows no signs of slowing down as market research firm BCC Research predicts that the clinical NGS market will increase to more than $10.5 Billion by 2022
Illumina has announced an expanded partnership with Integrated DNA Technologies (IDT) to develop solutions for next-generation sequencing (NGS) library preparation multiplexing and a co-marketing agreement that links Illumina library prep with the IDT Exome Enrichment
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
